Most of us don’t grow up across the street from a chemistry building or know from an early age that we want to be a scientist, but Alan Dyke, VP of Business Development for ProChem, Inc. (CTO of Boulder Scientific Company at the time of the interview) did and became a chemist. Dr. Alan Dyke, former colleague, and friend of Paolo’s, shares his career path and discusses the history and current state of the field of catalysis.

With a father that taught university-level chemistry, and a brother in the field, it may not be surprising that Alan Dyke became a chemist, but it is surprising is that he’s considered to be the outcast of the family for choosing a commercial career instead of taking an academic route. But, as he’ll passionately reveal, there are upsides to choosing a non-academic career.

Join us for a wonderful conversation where Paolo and Alan recount their shared history and the evolution of the catalysis field over recent decades. They discuss the evolution of homogeneous cross-coupling, biocatalysis, metathesis, and metallocene chemistry. Application of catalysis to fields as varied as pharmaceuticals and polymers is discussed, along with sustainability and other trends and dynamics in the field. Overcome your activation energy and join us!

Related episodes: 

• Season 1, Ep.2: Reinventing plastics, one reaction at a time
• Season 2, Ep.1: Chemistry: a modern American dream
• Season 2, Ep.6: The charm of the forgotten elements

Bonus content!

• Access bonus content curated by this episode’s guest by visiting www.thermofisher.com/chemistry-podcast for links to recent publications, podcasts, books, videos and more.
• View the video of this episode on www.thermofisher.com/chemistry-podcast.

A free thank you gift for our listeners! 

• Visit the episode website and request your free Bringing Chemistry to Life t-shirt.
• Use Podcast Code:  laBcheM in March or sc13nc3 in April

We read every email so please share your questions and feedback with us!

• Email helloBCTL@thermofisher.com

About Your Host

Born and raised in Italy, Paolo Braiuca, a PhD in pharmaceutical sciences, co-founded a startup company after conducting research in biocatalysis in Italy and the UK. He transitioned from R&D to business development, working in commercial, product management, and marketing roles in the specialty chemicals, biotechnology, and pharmaceutical markets in Germany and the UK. A busy father of four, if asked, he’ll call himself a “maker” at heart and enjoys inventing electronic devices in his free time.